Latest News

  • 19 Jul 2016

    TapImmune Appoints Dr. John N. Bonfiglio as President and Ch...

    JACKSONVILLE, Florida, July 19, 2016 / TapImmune, Inc. (TPIV), a clinical-stage immuno-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer & metastatic disease, announced today that the Company has...

    more >

  • 5 Jul 2016

    Q&A with TapImmune CEO Dr. Glynn Wilson, on a Vaccine t...

    A vaccine that can prevent the recurrence and metastasis of cancer would save countless lives. In the past century, vaccines have virtually eradicated life threatening diseases including polio and tuberculosis. Medical science may soon be at the point of delivering a cancer vaccine. Scientists at...

    more >